AbbVie to Buy Apogee in a $10.9 Billion Deal, Expanding its Immunology Portfolio
floriparesort.com – 23 June 2026 | AbbVie to buy Apogee in a massive $10.9 billion deal, marking a significant expansion of its immunology portfolio. The acquisition is expected to close…